Confirm the motor-neuron disease diagnosis before planning treatment abroad
ALS is primarily a clinical diagnosis supported by neurophysiology and by excluding other conditions that can resemble motor-neuron disease. Freiburg describes EMG as one of the most important additional tests and uses further laboratory and technical investigations mainly for differential diagnosis. Heidelberg's certified neuromuscular clinic evaluates motor-neuron diseases with detailed neurological and neurophysiological assessment.
- Neurological examination for upper- and lower-motor-neuron signs
- EMG and nerve-conduction studies
- Review of the pattern and speed of progression
- MRI and laboratory testing when needed to exclude structural, inflammatory, metabolic or other mimics
- Bulbar, respiratory and functional assessment
- Review of whether the phenotype suggests another motor-neuron or neuromuscular disorder
A second opinion can be useful when the diagnosis or phenotype is uncertain
Charité operates a specialist ALS and motor-neuron-disease clinic. A second opinion can be particularly useful when symptoms are atypical, progression has been unusually slow or rapid, sensory findings are prominent, previous studies conflict or another potentially treatable neuromuscular disorder remains possible.
Riluzole is part of disease-modifying treatment, not a cure
Freiburg describes riluzole as an ALS medication that can modestly prolong survival. Medication decisions should be individualized according to diagnosis, contraindications, laboratory monitoring and the patient's overall treatment plan. Genetic findings, disease subtype and access to approved or study-based options may also affect specialist discussions, but no therapy should be presented as a guaranteed reversal of ALS.
Respiratory assessment should happen before a crisis develops
Progressive respiratory-muscle weakness can be treated supportively with appropriately selected ventilation strategies and secretion management. Freiburg includes technical breathing support within its multidisciplinary ALS care. International patients should ask how respiratory function will be measured, when non-invasive ventilation should be considered and who will manage equipment after return home.
Swallowing, nutrition and communication require proactive planning
Bulbar weakness can affect speech, chewing and swallowing. Freiburg describes speech and swallowing therapy and, in advanced swallowing impairment, feeding through a gastrostomy as part of individualized care. The timing of nutrition support should be discussed before severe weight loss, dehydration or respiratory deterioration makes procedures more difficult.
- Speech and swallowing assessment
- Dietary and weight monitoring
- Communication aids when speech becomes difficult
- Gastrostomy discussion when oral intake is no longer safe or adequate
- Secretion and saliva management
Physiotherapy and assistive devices aim to preserve independence
Freiburg describes individualized physiotherapy, occupational therapy and speech therapy according to the dominant functional problem. Equipment planning may include mobility aids, orthoses, positioning systems, communication technology and home adaptations. The goal is to maintain safe function and quality of life, not to exhaust weakened muscles with generic exercise programs.
Genetic counseling can matter in selected ALS cases
Most ALS is sporadic, but Freiburg notes that a hereditary form is suspected in some patients and recommends genetic counseling in that situation. A specialist may consider genetic testing when there is a family history, young age at onset or another clinical reason. Results can affect family counseling and, for some genetic subtypes, eligibility discussions for targeted treatment or clinical research.
Palliative care is compatible with active neurological treatment
ALS care often requires early discussion of symptom control, respiratory choices, nutrition, communication, advance-care planning and patient preferences. Freiburg's interdisciplinary network includes palliative medicine. These discussions are not a signal that neurological care has stopped; they help align future treatment with the patient's goals before urgent decisions are required.
Be skeptical of unproven cure packages
Because ALS is serious and currently incurable, patients are vulnerable to expensive claims involving stem cells, supplements, devices or procedures that promise recovery without credible evidence. Ask whether a proposed treatment is approved for the specific indication or delivered within a registered clinical trial, what evidence supports it, what risks are known and who provides follow-up. A university-center second opinion can help separate evidence-based care from commercial claims.
What to send for a German ALS second opinion
A useful record package should allow the center to verify the diagnosis, understand the rate of progression and identify the most urgent supportive-care needs.
- Neurology and neuromuscular-clinic reports
- EMG and nerve-conduction reports, including earlier studies for comparison
- Brain and spine MRI reports and images if performed
- Pulmonary-function and respiratory assessments
- Swallowing, nutrition and weight history
- Current medication including riluzole and symptom treatments
- Genetic-test results and family history if available
- Current mobility, communication, ventilation and feeding equipment
- A specific question: confirm diagnosis, review progression, optimize supportive care, assess genetics or discuss clinical-study eligibility
Severe new breathing or swallowing deterioration needs local care first
A stable ALS second opinion can be planned internationally, but severe new breathlessness, inability to clear secretions, choking with inability to maintain hydration, acute aspiration concerns or another sudden deterioration should be assessed urgently where the patient is located. Travel should follow stabilization and clinical acceptance by the receiving center.
Official sources
Sources last checked 2026-09-01. Clinical pathways, eligibility and hospital procedures can change; confirm current requirements directly with the treating center.